Posts in tag

IBD


This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free. Username or Email Address Password Remember Me Register …

While they present a cost-saving opportunity, safety data on biosimilars is still limited, warns IBD specialist There is an absence of data on adverse reactions or potential development of anti-drug …